Neoantigen Therapy in Clinical Trials: Where the Science Stands Today
Neoantigen targeted therapy is progressing through clinical trials, with encouraging early results in melanoma, lung cancer, and other solid tumors. Personalized cancer vaccines and neoantigen-specific T cell therapies are being tested in various settings, and the data are being watched closely by researchers, investors, and clinicians. The neoantigen targeted therapy market's future will...
0 Комментарии 0 Поделились 176 Просмотры 0 предпросмотр